Global S&T Development Trend Analysis Platform of Resources and Environment
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines | |
Miquel Oliu-Barton and Guntram B. Wolff | |
2021-11-03 | |
出版年 | 2021 |
国家 | 欧洲 |
领域 | 资源环境 |
英文摘要 | By Miquel Oliu-Barton, Bary S R Pradelski, Yann Algan, Michael G Baker, Agnes Binagwaho, Gregory J Dore, Ayman El-Mohandes, Arnaud Fontanet, Andreas Peichl, Viola Priesemann, Guntram B Wolff, Gavin Yamey, Jeffrey V Lazarus
Summary There is increasing evidence that elimination strategies have resulted in better outcomes for public health, the economy, and civil liberties than have mitigation strategies throughout the first year of the COVID-19 pandemic. With vaccines that offer high protection against severe forms of COVID-19, and increasing vaccination coverage, policy makers have had to reassess the trade-offs between different options. The desirability and feasibility of eliminating SARS-CoV-2 compared with other strategies should also be re-evaluated from the perspective of different fields, including epidemiology, public health, and economics. To end the pandemic as soon as possible—be it through elimination or reaching an acceptable endemic level—several key topics have emerged centring around coordination, both locally and internationally, and vaccine distribution. Without coordination it is difficult if not impossible to sustain elimination, which is particularly relevant in highly connected regions, such as Europe. Regarding vaccination, concerns remain with respect to equitable distribution, and the risk of the emergence of new variants of concern. Looking forward, it is crucial to overcome the dichotomy between elimination and mitigation, and to jointly define a long-term objective that can accommodate different political and societal realities. |
URL | 查看原文 |
来源平台 | Bruegel |
文献类型 | 科技报告 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/341929 |
专题 | 资源环境科学 |
推荐引用方式 GB/T 7714 | Miquel Oliu-Barton and Guntram B. Wolff. Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines,2021. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论